GPT LOGO_2 color.png
  • [email protected]
  • (888) 899-5899
  • facebook
  • twitter
  • linkedin
  • About
    • GemPharmatech USA
    • GemPharmatech Co., Ltd.
    • Facilities
  • Models

    Knockout All Project (KOAP)

    • Signaling Pathways

    Immunodeficient Mouse Models

    • Human CDX Tumor Models

    Tool Mice

    • Cre and Dre Mice

    Disease Mouse Models

    • Metabolic Disease Mouse Models
    • Neurodegenerative Disease Mouse Models
    • Rare Disease Mouse Models
    • Spontaneous Tumor Mouse Models

    Humanized Immune Checkpoint Mouse Models

    • Syngeneic Mouse Tumor Models

    Humanization of Mouse Models for Preclinical R&D

  • Services
    • Custom Mouse Model Generation
    • Preclinical Efficacy Services
    • Custom Breeding Services
    • Cell Line Customization
    • Enrollment
    • Germ-Free Testing Services
  • News & Resources

    News

    • GPT and Charles River Laboratories Sign Exclusive Agreement to Distribute Next-Gen NCG Portfolio
    • GemPharmatech Goes Public on Shanghai Stock Exchange
    • More News...

    Events

    • WODC 2022
    • Tumor Models 2022
    • More Events...

    Webinars

    • Protein O-GlcNAcylation: a sweet “weep & sweep” for helminth expulsion
    • Latest OnDemand Webinar
    • More Webinars...

    Resources

  • Careers
  • Contact Us
animation circle

News & Announcements

  • Home
  • GemPharmatech News

GemPharmatech and Charles River Laboratories Sign Exclusive Agreement to Distribute Next Generation NCG Portfolio

July 26, 2022

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange

April 25, 2022

Recent Publication in Mammalian Genomics

March 09, 2022

Moving from Discovery to Clinic with Genetically Engineered Mouse Models

February 22, 2022
  • « Previous
  • 1
  • 2
  • 3
  • Next »

Categories

  • News
  • Events
lineline
GPT LOGO_KO_white.png
  • facebook
  • twitter
  • linkedin

About

GemPharmatech is a leading provider of genetically engineered mouse models (GEMMs) and preclinical services to global R&D communities.

Explore

  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Health Testing Program
Email

[email protected]

Phone

(888) 899-5899

Address

1521 Concord Pike, Suite 301,
Wilmington, DE 19803, USA

© Copyright 2022 Gempharmatech. All Rights Reserved.